AU2002324944A1 - Distinguishing agonists, antagonists, and inverse agonists using pwr - Google Patents

Distinguishing agonists, antagonists, and inverse agonists using pwr

Info

Publication number
AU2002324944A1
AU2002324944A1 AU2002324944A AU2002324944A AU2002324944A1 AU 2002324944 A1 AU2002324944 A1 AU 2002324944A1 AU 2002324944 A AU2002324944 A AU 2002324944A AU 2002324944 A AU2002324944 A AU 2002324944A AU 2002324944 A1 AU2002324944 A1 AU 2002324944A1
Authority
AU
Australia
Prior art keywords
agonists
pwr
antagonists
distinguishing
inverse
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002324944A
Other languages
English (en)
Inventor
Scott Cowell
Victor J. Hruby
Zdzislaw Salamon
Gordon Tollin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Arizona Board of Regents of University of Arizona
Original Assignee
Arizona Board of Regents of University of Arizona
University of Arizona
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Arizona Board of Regents of University of Arizona, University of Arizona filed Critical Arizona Board of Regents of University of Arizona
Publication of AU2002324944A1 publication Critical patent/AU2002324944A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/566—Immunoassay; Biospecific binding assay; Materials therefor using specific carrier or receptor proteins as ligand binding reagents where possible specific carrier or receptor proteins are classified with their target compounds
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54366—Apparatus specially adapted for solid-phase testing
    • G01N33/54373—Apparatus specially adapted for solid-phase testing involving physiochemical end-point determination, e.g. wave-guides, FETS, gratings
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
    • G01N2333/72—Assays involving receptors, cell surface antigens or cell surface determinants for hormones
    • G01N2333/726—G protein coupled receptor, e.g. TSHR-thyrotropin-receptor, LH/hCG receptor, FSH

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Materials By Optical Means (AREA)
  • Peptides Or Proteins (AREA)
  • Laminated Bodies (AREA)
AU2002324944A 2001-09-07 2002-09-09 Distinguishing agonists, antagonists, and inverse agonists using pwr Abandoned AU2002324944A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US31824101P 2001-09-07 2001-09-07
US60/318,241 2001-09-07
PCT/US2002/028766 WO2003023361A2 (fr) 2001-09-07 2002-09-09 Distinction d'agonistes, d'antagonistes et d'agonistes inverses par resonance guides d'ondes du plasmon

Publications (1)

Publication Number Publication Date
AU2002324944A1 true AU2002324944A1 (en) 2003-03-24

Family

ID=23237312

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002324944A Abandoned AU2002324944A1 (en) 2001-09-07 2002-09-09 Distinguishing agonists, antagonists, and inverse agonists using pwr

Country Status (2)

Country Link
AU (1) AU2002324944A1 (fr)
WO (1) WO2003023361A2 (fr)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69305160T2 (de) * 1992-04-22 1997-04-30 Ecole Polytech Lipidmembranen fur biosensoranwendungen

Also Published As

Publication number Publication date
WO2003023361A2 (fr) 2003-03-20
WO2003023361A3 (fr) 2003-06-12

Similar Documents

Publication Publication Date Title
IL148545A0 (en) Substituted 2-thio-3,5-dicyano-4-aryl-6-aminopyridines and the use thereof
AU9684401A (en) Hedgehog antagonists, methods and uses related thereto
PL366233A1 (en) Substituted pyridoindoles as serotonin agonists and antagonists
HK1078266A1 (en) Substituted 2-thio-3,5-dicyano-4-phenyl-6-aminopyridines and the use of the same
EP1463412A4 (fr) Composition comprenant des extraits de wenguanguo, ses procedes de preparation et ses utilisations
AU1772300A (en) Glucagon antagonists/inverse agonists
IL154604A0 (en) Guanidinobenzamides as mc4-r agonists
MXPA03009220A (es) Derivados de bipiperidinilo y su uso como inhibidores de receptores de quimiocina.
AU2002234076A1 (en) Construction composition, structure, and method
AU2002223501A1 (en) Glucagon antagonists/inverse agonists
AU4217299A (en) Pth1r and pth3r receptors, methods and uses thereof
AU2002223500A1 (en) Glucagon antagonists/inverse agonists
ZA200100978B (en) Muscarinic agonists and antagonists.
AU2002329873A1 (en) Halogenated calixpyrroles, calixpyridinopyrroles and calixpyridines, and uses thereof
PL371059A1 (en) 5-phenylpyrimidines, agents comprising the same, method for production and use thereof
MXPA03003796A (es) Procedimiento y dispositivos de aplicacion por vertido.
AU6635800A (en) Pyridomorphinans, thienomoprhinans and use thereof
AU2002361337A1 (en) Amphoteric polysaccharide, composition and use
AU2001244741A1 (en) Interpretation managing system, interpretation managing system, and interpretation managing program
AU3883800A (en) Hob-bp2h compositions, methods and uses thereof
AU5861900A (en) Receptor agonists and antagonists
AU2001232089A1 (en) Compound, composition and use
AU2002324944A1 (en) Distinguishing agonists, antagonists, and inverse agonists using pwr
AU1582602A (en) Drill, screw and set comprising drill and screw
AU2002356624A1 (en) Ptp10d, tec and edtp involved in triglycerid-metabolism

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase